Skip to content
-
CBD for children with Dravet’s and intractable seizures (Video)
-
Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy (PubMed)
-
Medicinal marijuana stops seizures, brings hope to a little girl (Gazette, Colorado Springs)
-
Cannabinoids for epilepsy (PubMed)
-
Cannabis, cannabidiol, and epilepsy – From receptors to clinical response (PubMed)
-
The non-psychotropic plant cannabinoids, cannabidivarin (CBDV) and cannabidiol (CBD), activate and desensitize transient receptor potential vanilloid 1 (TRPV1) channels in vitro: potential for the treatment of neuronal hyperexcitability (ACS Publications)
-
Chronic administration of cannabidiol to healthy volunteers and epileptic patients (PubMed)
-
Endocannabinoid system protects against cryptogenic seizures (PubMed)
-
Seizing an opportunity for the endocannabinoid system (Pub Med)
-
Cannabidiol: promise and pitfalls (Pub Med)
-
Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatricdisorders (PubMed)
-
Report of a parent survey of cannabidiol-enriched cannabis use in pediatrictreatment-resistant epilepsy (Epilepsy Association of Utah)
-
From the Editors: Cannabidiol and medical marijuana for the treatment of epilepsy (PubMed)
-
Cannabidivarin (CBDV) suppressespentylenetetrazole (PTZ)-inducedincreases in epilepsy-related gene expression (PubMed)
-
Cannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures(PubMed)
-
Cannabidiol displays antiepileptiform and antiseizure properties in vitro and in vivo (PubMed)
-
Hypnotic and antiepileptic effects of cannabidiol (PubMed)
-
The cannabinoids as potential antiepileptics (PubMed)
-
Cannabidiol–antiepileptic drug comparisons and interactions in experimentally induced seizures in rats (PubMed)
-
Activation of the Cannabinoid Type-1 Receptor Mediates the Anticonvulsant Properties of Cannabinoids in the Hippocampal Neuronal Culture Models of Acquired Epilepsy and Status Epilepticus (The American Society for Pharmacology and Experimental Therapeutics)
-
Analysis of endocannabinoid signaling elements and related proteins in lymphocytes of patients with Dravet syndrome (Pharmacology Research and Perspectives)
-
Assessment of the role of CB receptors in cannabinoid 1 anticonvulsant effects (European Journal of Pharmacology)
-
Cannabidiol Displays Antiepileptiform and Antiseizure Properties In Vitro and In Vivo (The American Society for Pharmacology and Experimental Therapeutics)
-
Cannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures (ScienceDirect)
-
Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders (Department of Neurology, Comprehensive Epilepsy Center)
-
Cannabidiol Rescues Acute Hepatic Toxicity and Seizure Induced by Cocaine (Mediators of Inflammation)
-
Cannabidivarin (CBDV) suppresses pentylenetetrazole (PTZ)-induced increases in epilepsy-related gene expression (School of Chemistry, Food and Nutritional Sciences and Pharmacy, The University of Reading, Berkshire, UK)
-
Cannabidivarin is anticonvulsant in mouse and rat (British Journal of Pharmacology)
-
Cannabidivarin-rich cannabis extracts are anticonvulsant in mouse and rat via a CB1 receptor-independent mechanism (British Journal of Pharmacology)
-
Cannabinoids for pediatric epilepsy (Division of Pediatric Neurology, University of Utah School of Medicine)
-
Cannabinoids in the Treatment of Epilepsy (The New England Journal of Medicine)
-
Cannabis, Cannabinoids and Tinnitus (Journal of Pharmacology and Drug Metabolism)
-
CBD-enriched medical cannabis for intractable pediatric epilepsy The current Israeli experience (ScienceDirect)
-
Epidiolex (Cannabidiol) in Treatment Resistant Epilepsy (Nationwide Children’s Hospital)
-
Evidence for a physiological role of endocannabinoids in the modulation of seizure threshold and severity (European Journal of Pharmacology)
-
On the application of cannabis in paediatrics and epileptology (Neuroendocrinology Letters)
-
Redistribution of CB1 Cannabinoid Receptors in the Acute and Chronic Phases of Pilocarpine-Induced Epilepsy (PLOS)
-
Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy (National Institute of Health)
-
The case for assessing cannabidiol in epilepsy (Epilepsia)
-
The Endogenous Cannabinoid System Regulates Seizure Frequency and Duration in a Model of Temporal Lobe Epilepsy (The American Society for Pharmacology and Experimental Therapeutics)
-
Understanding Cannabinoids and Epilepsy (Brain Treatment Center of Atlanta)
